| Original language | English (US) |
|---|---|
| Pages (from-to) | e78-e140 |
| Journal | Journal of the American College of Cardiology |
| Volume | 61 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jan 29 2013 |
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of the American College of Cardiology, Vol. 61, No. 4, 29.01.2013, p. e78-e140.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction
T2 - A report of the American college of cardiology foundation/american heart association task force on practice guidelines
AU - O'Gara, Patrick T.
AU - Kushner, Frederick G.
AU - Ascheim, Deborah D.
AU - Casey, Donald E.
AU - Chung, Mina K.
AU - De Lemos, James A.
AU - Ettinger, Steven M.
AU - Fang, James C.
AU - Fesmire, Francis M.
AU - Franklin, Barry A.
AU - Granger, Christopher B.
AU - Krumholz, Harlan M.
AU - Linderbaum, Jane A.
AU - Morrow, David A.
AU - Newby, L. Kristin
AU - Ornato, Joseph P.
AU - Ou, Narith
AU - Radford, Martha J.
AU - Tamis-Holland, Jacqueline E.
AU - Tommaso, Carl L.
AU - Tracy, Cynthia M.
AU - Woo, Y. Joseph
AU - Zhao, David X.
N1 - Funding Information: The Task Force makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of relationships with industry and other entities (RWI) among the members of the writing committee. All writing committee members and peer reviewers of the guideline are required to disclose all current healthcare related relationships, including those existing 12 months before initiation of the writing effort. In December 2009, the ACCF and AHA implemented a new RWI policy that requires the writing committee chair plus a minimum of 50% of the writing committee to have no relevant RWI. ( Appendix 1 includes the ACCF/AHA definition of relevance .) These statements are reviewed by the Task Force and all members during each conference call and/or meeting of the writing committee, and members provide updates as changes occur. All guideline recommendations require a confidential vote by the writing committee and must be approved by a consensus of the voting members. Members may not draft or vote on any text or recommendations pertaining to their RWI. Members who recused themselves from voting are indicated in the list of writing committee members, and specific section recusals are noted in Appendix 1 . Authors' and peer reviewers' RWI pertinent to this guideline are disclosed in Appendixes 1 and 2 , respectively. In addition, to ensure complete transparency, writing committee members' comprehensive disclosure information—including RWI not pertinent to this document—is available as an online supplement. Comprehensive disclosure information for the Task Force is also available online at http://www.cardiosource.org/ACC/About-ACC/Who-We-Are/Leadership/Guidelines-and-Documents-Task-Forces.aspx . The work of writing committees is supported exclusively by the ACCF and AHA without commercial support. Writing committee members volunteered their time for this activity.
PY - 2013/1/29
Y1 - 2013/1/29
UR - https://www.scopus.com/pages/publications/84872698656
UR - https://www.scopus.com/pages/publications/84872698656#tab=citedBy
U2 - 10.1016/j.jacc.2012.11.019
DO - 10.1016/j.jacc.2012.11.019
M3 - Article
C2 - 23256914
AN - SCOPUS:84872698656
SN - 0735-1097
VL - 61
SP - e78-e140
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 4
ER -